| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Leucine-rich repeat and fibronectin type-III domain-containing protein 3 (8-58 aa) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
LRFN3 |
| Gene ID: |
79414 |
| Uniprot ID: |
LRFN3_HUMAN |
| Immunogen Region: |
8-58 aa |
| Specificity: |
This antibody detects endogenous levels of LRFN3 at Human/Mouse/Rat |
| Immunogen: |
Synthesized peptide derived from the human LRFN3 at the amino acid range 8-58 |
| Function | Cell adhesion molecule that mediates homophilic cell-cell adhesion in a Ca(2+)-independent manner. Promotes neurite outgrowth in hippocampal neurons. |
| Protein Name | Leucine-Rich Repeat And Fibronectin Type-Iii Domain-Containing Protein 3Synaptic Adhesion-Like Molecule 4 |
| Database Links | Reactome: R-HSA-8849932 |
| Cellular Localisation | Cell MembraneSingle-Pass Type I Membrane ProteinCell ProjectionAxonDendriteSynapsePresynaptic Cell MembranePostsynaptic Cell Membrane |
| Alternative Antibody Names | Anti-Leucine-Rich Repeat And Fibronectin Type-Iii Domain-Containing Protein 3 antibodyAnti-Synaptic Adhesion-Like Molecule 4 antibodyAnti-LRFN3 antibodyAnti-SALM4 antibodyAnti-UNQ5865 antibodyAnti-PRO34192 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
